Drug intelligence / Profile preview

Lolium perenne extract

Development stage
Unknown
Lead developer
Allergy Therapeutics
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal, Percutaneous
01

Overview

Lolium perenne extract is a biological allergenic extract derived from the pollen of *Lolium perenne* (perennial ryegrass), developed by Instituto de Inmunología y Alergia INMUNAL S.A.U. It is designed for use as both a diagnostic tool (via skin prick testing) and an immunotherapeutic agent for patients suffering from IgE-mediated hypersensitivity to grass pollens. The extract contains a complex mixture of allergenic proteins, most notably the major allergens Lol p 1 (a β-expansin) and Lol p 5 (a group 5 allergen), which are the primary components responsible for triggering allergic responses. By exposing the immune system to controlled amounts of these allergens, the extract aims to induce desensitization and reduce symptoms of allergic rhinitis and allergic asthma. It has been evaluated in Phase II clinical trials (such as NCT01394289) for biological standardization and characterization.

Other names
Lolium perenne pollen extractperennial ryegrass pollen extractperennial ryegrass extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Lolium perenne extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lolium perenne extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call